A Phase 1a/1b Study of FPA150, an Anti-B7-H4 Antibody, in Patients with Advanced Solid Tumors

  • Markman, Ben (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Reference Number: 48866
NMA SSA Reference Number: SSA/48866/MonH-2019-165476(v1)
Monash Health Ref: RES-19-0000-122X
StatusFinished
Effective start/end date30/04/19 → 29/04/24

Keywords

  • clinical trial
  • phase 1 study
  • treatment efficacy
  • solid tumours